PolyPeptide Group AG (PPGN) — Capital Reinvestment Ratio
PolyPeptide Group AG (PPGN) has a Capital Reinvestment Ratio of 0.98x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF49.66 Million) in capital expenditures (CHF48.68 Million). Check PolyPeptide Group AG tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PolyPeptide Group AG Capital Reinvestment Ratio (2018–2024)
This chart tracks PolyPeptide Group AG's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see PolyPeptide Group AG (PPGN) cash flow conversion.
Annual Capital Reinvestment Ratio for PolyPeptide Group AG (2018–2024)
Year-by-year Capital Reinvestment Ratio for PolyPeptide Group AG from 2018 to 2024. See PPGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | CHF89.40 Million | CHF86.97 Million | ▼ -37.4% |
| 2023 | 1.55x | CHF36.48 Million | CHF56.73 Million | ▼ -89.2% |
| 2022 | 14.43x | CHF5.46 Million | CHF78.76 Million | ▲ +964.7% |
| 2021 | 1.35x | CHF57.35 Million | CHF77.71 Million | ▲ +65.0% |
| 2020 | 0.82x | CHF49.48 Million | CHF40.62 Million | ▲ +131.6% |
| 2019 | 0.35x | CHF55.60 Million | CHF19.70 Million | ▼ -55.6% |
| 2018 | 0.80x | CHF22.94 Million | CHF18.30 Million | — |